Consolidated Condensed Statements of Equity - USD ($) $ in Thousands		Total	Controlling Member	Noncontrolling Interest
Balance, January 1 at Dec. 31, 2015		$ 2,639,586	$ 2,344,155	$ 295,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		113,153	107,450	5,703
Other comprehensive income/(loss)	[1]	61,858	61,858	0
Comprehensive income		175,011	169,308	5,703
Cash dividends declared:
Preferred stock ($3,100 per share for the six months ended June 30, 2017 and 2016)		(3,100)	(3,100)	0
Common stock ($.18 and $.14 per share for the six months ended June 30, 2017 and 2016, respectively)		(32,991)	(32,991)	0
Common stock repurchased	[2]	(89,698)	(89,698)	0
Common stock issued for:
Stock options and restricted stock - equity awards		1,509	1,509	0
Stock-based compensation expense		7,796	7,796	0
Dividends declared - noncontrolling interest of subsidiary preferred stock		(5,703)	0	(5,703)
Tax benefit/(benefit reversal) - stock based compensation expense		(486)	(486)	0
Balance, June 30 at Jun. 30, 2016		2,691,924	2,396,493	295,431
Balance, January 1 at Dec. 31, 2016		2,705,084	2,409,653	295,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		153,592	147,920	5,672
Other comprehensive income/(loss)	[1]	10,192	10,192	0
Comprehensive income		163,784	158,112	5,672
Cash dividends declared:
Preferred stock ($3,100 per share for the six months ended June 30, 2017 and 2016)		(3,100)	(3,100)	0
Common stock ($.18 and $.14 per share for the six months ended June 30, 2017 and 2016, respectively)		(42,404)	(42,404)	0
Common stock repurchased		(4,953)	(4,953)	0
Common stock issued for:
Stock options and restricted stock - equity awards		4,309	4,309	0
Stock-based compensation expense		9,840	9,840	0
Dividends declared - noncontrolling interest of subsidiary preferred stock		(5,672)	0	(5,672)
Tax benefit/(benefit reversal) - stock based compensation expense		0	0	0
Balance, June 30 at Jun. 30, 2017		$ 2,826,888	$ 2,531,457	$ 295,431

[1] Due to the nature of the preferred stock issued by FHN and its subsidiaries, all components of Other comprehensive income/(loss) have been attributed solely to FHN as the controlling interest holder.

[2] 2016 includes $86.4 million repurchased under share repurchase programs.